Summary & Overview
HCPCS J0360: Injection, Hydralazine HCl up to 20 mg
HCPCS Level II code J0360 designates an injection of hydralazine hydrochloride, up to 20 mg, a short-acting vasodilator used for acute blood pressure management. Nationally, this code matters for billing of parenteral antihypertensive therapy in outpatient and emergency settings, where accurate coding drives appropriate reimbursement, inventory control, and clinical documentation.
This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how J0360 is used across common sites of care, typical billing and clinical context for hydralazine injections, and what to expect in payer coverage patterns. The publication highlights benchmarks for utilization and reimbursement, recent policy or coding clarifications affecting injectable drug billing, and practical coding considerations tied to service lines.
The report is intended for revenue cycle professionals, clinicians involved in acute antihypertensive management, and policy analysts tracking medication administration coding. It supplies clinical context for the drug service, summarizes payer coverage scope, and outlines areas where coding precision impacts claims processing and payment outcomes.
Billing Code Overview
HCPCS Level II code J0360 describes an injection of hydralazine hydrochloride, up to 20 mg. The service is a parenteral medication administration involving a single injectable dose of hydralazine HCl for acute management of hypertension or related vasodilatory indications. Typical site of service is outpatient clinical settings, including hospital outpatient departments, emergency departments, and physician offices where injectable antihypertensive therapy is provided.
Service type: Drug administration / Injectable medication.
Typical site of service: Hospital outpatient, emergency department, physician office, outpatient infusion/medication administration area.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old woman with long-standing hypertension who presents to the emergency department with acute hypertensive urgency (markedly elevated blood pressure with symptoms such as headache or chest discomfort but without end-organ damage). The treating physician orders a parenteral antihypertensive to achieve controlled lowering of blood pressure. A single dose of intravenous or intramuscular hydralazine hydrochloride, up to 20 mg, is prepared and administered by nursing staff under direct physician or advanced practice provider order. Documentation in the medical record includes indication (e.g., acute severe hypertension), time and route of administration, exact dose given, lot number and expiration for the medication, patient vital signs before and after administration, any adverse reactions, and who administered the injection. Typical sites of service include the emergency department, inpatient hospital ward, observation unit, and occasionally outpatient infusion or clinic settings when immediate parenteral blood pressure control is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | When another service or procedure not normally reported together is performed on the same day and is distinct/independent from hydralazine injection administration |
25 |